Atlas of drug mechanisms and their impact on cancer biology using machine learning
Investors 2
Funding Rounds 1
| Date | Series | Amount | Investors |
| 29.09.2022 | Seed | $11M | - |
Mentions in press and media 4
| Date | Title | Description |
| 29.09.2022 | Meliora Therapeutics Raises $11 Million Seed Financing to Develop First Mechanism Of Action Atlas in Oncology | Meliora Therapeutics, a biotech company pioneering a machine learning-driven platform to decipher oncology drugs’ true mechanisms-of-action, announced the close of an $11M seed financing round led by HOF Capital and ZhenFund, with participa... |
| 29.09.2022 | Biotech Meliora Therapeutics Gets $11 Million Seed Financing for Cancer Treatments | Biotech startup Meliora Therapeutics Inc. has secured $11 million in seed funding to try to uncover how cancer medicines actually work and hopefully develop new ones that have a greater chance of stopping the disease.
Some 97% of cancer dru... |
| 29.09.2022 | Meliora Therapeutics Raises $11M in Seed Financing | Meliora Therapeutics, a Menlo Park,Ca-based biotech company, raised $11M in Seed funding.
The round was led by HOF Capital, with participation from ZhenFund, Obvious Ventures, Village Global, BrightEdge, Pebblebed, Axial, Olive Capital, Mic... |
| - | Meliora Therapeutics | “Bringing together modern molecular fingerprinting, machine learning, and cutting edge biology” |
Reviews 0